Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis 1513

Max Ratio

Dividend Yield

8.66 %

5Y Dividend Growth

9.00 %

Consecutive Years

5Y Average Payout Ratio

65.14 %

Dividend History 1513

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 8.66 %
Consecutive Years 0
Forward Annual Dividend 2.68 HKD
Consistent Years 0
Dividend CAGR 3Y -0.53 %
Continuous Dividends
Dividend CAGR 5Y 1.65 %
Payout Ratio TTM
Dividend CAGR 10Y 20.99 %
Ex Dividend Date 06/13/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth 1513

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin 1513

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income 1513

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM 1513

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio 1513

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Livzon Pharmaceutical Group Inc 1513

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself 1513

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 11.89
Forward PE
Enterprise Value Revenue 1.97
Price Sales TTM 2.80
Enterprise Value EBITDA 7.62
Price Book MRQ 1.85

Livzon Pharmaceutical Group Inc Dividends: 3.87 % Yield, History, Payment Schedule

1513
Current price
30.96 HKD +0.24 HKD (+0.78%)
Last closed 30.72 HKD
ISIN CNE100001QV5
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 33 164 745 174 HKD
Yield for 12 month +14.88 %
1Y
3Y
5Y
10Y
15Y
1513
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+11 809 353 454 HKD

Last Year

+12 426 896 807 HKD

Current Quarter

+3 090 583 746 HKD

Last Quarter

+3 179 743 761 HKD

Current Year

+7 729 277 936 HKD

Last Year

+7 655 690 318 HKD

Current Quarter

+2 073 846 928 HKD

Last Quarter

+2 065 532 782 HKD
EBITDA 2 870 356 357 HKD
Operating Margin TTM 24.54 %
Price to Earnings 11.89
Return On Assets TTM 6.38 %
PEG Ratio
Return On Equity TTM 16.43 %
Wall Street Target Price 300.92 HKD
Revenue TTM 11 843 655 782 HKD
Book Value 15.71 HKD
Revenue Per Share TTM
Dividend Share 1.10 HKD
Quarterly Revenue Growth YOY 1.60 %
Dividend Yield 8.66 %
Gross Profit TTM 7 636 630 230 HKD
Earnings per share 2.38 HKD
Diluted Eps TTM 2.38 HKD
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -1.70 %
Profit Margin 18.08 %

Technical Indicators 1513

For 52 Weeks

23.93 HKD 41.84 HKD
50 Day MA 33.67 HKD
Shares Short Prior Month
200 Day MA 30.89 HKD
Short Ratio
Shares Short
Short Percent